Recent large-scale breast cancer genome studies have revealed that each molecular subtype has specific pattern of genomic alterations and notably, tumors of HER2-enriched and basal-like subtypes harbor many more rearrangements than the luminal A subtype, which primarily consists of receptor positive breast tumors [2]. The gene discussed is ERBB2; the disease is breast carcinoma.